ALKERMES | Fremdkapital

Loan Capital Veränderung Datum
AbbVie USD 55.63B 181M 2023-09
Acadia Pharmaceuticals USD 0 0 2022-06
ALKERMES USD 288.37M 635K 2023-09
Amgen USD 63.17B 4.13B 2023-12
Bristol-Myers Squibb USD 32.14B 2.52B 2023-09
Eli Lilly USD 17.92B 956.9M 2023-09
Gilead Sciences USD 23.19B 1.98B 2023-09
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.23B 49.79M 2023-12
Malin Corporation EUR 0 0 2021-12
Merck USD 33.97B 100M 2023-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Otsuka Holdings JPY 125.76B 1.35B 2023-09
Pfizer USD 61.05B 308M 2023-09
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



ALKERMES Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.